Request for EOIs: Canadian Bioproduction Technologies Research and Development Partnering Delegation to France

Aims

• This delegation aims to explore opportunities for Canadian small and medium-sized enterprises (SMEs) to cooperate with potential French partners (SMEs, research institutions and large French companies), with a view to developing co-innovation projects relating to bioproduction technologies.

Focus Areas

• The delegation will focus on the following areas:
  • validating Canadian technologies in the French, European and/or other markets
  • adapting Canadian technologies to the characteristics of the French, European and/or other markets
  • jointly developing new products and/or services by combining Canadian and French technologies

Program

• The program will include a number of business-to-business (B2B) meetings and activities with leading organizations in the French biotherapy and bioproduction sector. The program will focus on creating co-innovation collaboration opportunities.
• Specifically, the program will include the following:
  • preparatory meetings and briefing before departure as well as mentoring on pitching techniques in France
  • information sessions providing market insights and co-innovation funding opportunities
  • pitch sessions by Canadian participants to French stakeholders, including French companies (multinationals and SMEs), research labs, centres of excellence and innovation hubs, technology clusters, and other incubators or accelerators
  • targeted B2B meetings with French companies (multinationals and SMEs) and research centres to discuss co-innovation opportunities
  • networking with key players in the French bioproduction technology ecosystem
  • visits to major research centres in the biotherapy and bioproduction technology ecosystem in Lyon and Paris
  • participation in the Bioproduction Congress in Lyon and related business activities

Funding Information

• CIIP may provide financial support to eligible Canadian SMEs for up to 50% of eligible expenses, which include, but are not limited to the following:
  • economy class airfare
  • local transportation
  • accommodation
  • per diems
  • conference registration fees

Eligibility Criteria

• Canadian companies interested to participate in this delegation to France must meet the following requirements:
  • profit-oriented SME incorporated in Canada
  • experience commercializing technology in domestic or international markets
  • capacity for and interest in co-developing technology with French partners
  • committed to expanding to the French and European markets
  • sufficient working capital and human resources to undertake a multi-year ‑collaboration project and commercialize the results
• Technology and products of particular interest for this delegation include the following:
  • Bioproduction technologies:
    • Bioproduction systems and methods:
      • innovative bioreactors: single-use, infusion, continuous, microfluidic
      • centralized, distributed or point-of-care (PoC) production
      • automation and digitalization: artificial intelligence, robotics, online control
      • fill and finish technologies: syringes, vials, lyophilization
      • process security: cybersecurity, anti-contamination solutions
    • Manufacturing process optimization:
      • innovative expression systems: highly productive cell lines, yeasts, modified bacteria
      • continuous production and infusion technologies
      • next generation of optimized growing media and substrates
      • biocatalysts and enzymes for process intensification
    • Analytical technologies and quality control:
      • real-time release (RTR) methods
      • multi-omics analysis (proteomics, transcriptomics, metabolomics)
      • biosensors and advanced characterization tests
      • innovative potency and immunogenicity testing
  • Technologies for developing biotherapies and innovative therapies that underpin bioproduction:
    • innovative biologic therapies
    • vectorization and delivery technologies
    • digital tools for discovery and development

For more information, visit Government of Canada.